Medical research

Antipsychotic agents

Long-Acting Injectable Antipsychotics Hold Promise in Treating Schizophrenia

According to recent research from Italy, long-acting injectable antipsychotics (LAIs) have the potential to significantly impact treatment adherence and disease trajectories in patients with schizophrenia. However, their utilization in clinical practice remains limited. The study, conducted by Alessandra Massaro and colleagues, surveyed Italian psychiatrists to evaluate their attitudes towards LAIs